U.S. Patent Trial and Appeal Board (PTAB) Archives - PharmaLive

Gilead Versus HHS: Gilead Loses 2nd Patent Invalidation Challenge

Business, Department of Health and Human Services (HHS), Lawsuits, Patent Challenges, Trump Administration, U.S. Centers for Disease Control and Prevention, U.S. Patent Trial and Appeal Board (PTAB)

Gilead Sciences lost yet another challenge to the company’s U.S. patent to Truvada for HIV prevention, or PrEP.

February 21, 2020/by BioSpace

Multiple Sclerosis Update: Biogen, Sanofi, Active, Adamas and Novartis

Blockbusters, Bruton's Tyrosine Kinase (BTK) Inhibitors, Business, Clinical Trial Endpoints, Clinical Trials, CNS damage, MS with walking impairment, Multiple Sclerosis, Neurology, Patent Challenges, R&D, Secondary Endpoints, Shares, U.S. Patent Trial and Appeal Board (PTAB)

Biogen successfully fended off a patent challenge from generic company Mylan over the multiple sclerosis (MS) drug Tecfidera.

February 6, 2020/by BioSpace